PreciDIAB

Home » PreciDIAB

DIGITAL PRECIDIAB MEETING
Monday, December 7^th, 2020

ABOUT THE EVENT

The National Center for Precision Diabetic Medicine and PreciDIAB Initiative, are organising a one-day networking meeting: public-private and private-private partnerships in the field of diabetes and comorbidities. PreciDIAB Initiative is the business club of PreciDIAB.
More information: https://www.precidiab.org/partnership/precidiab-initiative/.

REGISTRATION

To take part in PreciDIAB Meeting, you must be registered for BioFIT event
Registration to PreciDIAB Meeting is free but mandatory

PROGRAMME | December 10th

9:00-10:00 AM CET

PreciDIAB Academia-Industry R&D Collaborations

PreciDIAB is creating favourable conditions for efficient Public/Private collaborative research (diagnosis and follow-up tools, drugs, medical and IT devices), and setting up a comprehensive “machinery” to generate scientific outcomes and exploit them smoothly.

Introducing PreciDIAB, Professor Philippe Froguel
Collaborative success stories
- Medical device clinical evaluation, Professor Robert Caiazzo
- Medical diagnosis, Dr Amélie Bonnefond

Moderators:

Matthias Vandesquille, Project Manager – PreciDIAB National Center
Xavier Martin Benlloch, Technology Transfer Officer, Eurasanté

12:00–12:30 PM CET

Call Launch : DeepTech for Cardiometabolic diseases

The Acceleration Program by Eurasanté launches the call DeepTech for Cardiometabolic diseases.

Open to challenging bioentrepreneurs, start-ups, SMEs willing to shorten the time-to-market of their projects and penetrate the European health market: fast-track connections with PreciDIAB network, investors network, and a tailor-made support from the Eurasanté team.

Introducing the call:

Rémi Verstraete, Start-up advisor, Bio-Accelerator, Eurasanté
Caroline Ramspacher, Innovation & Entrepreneurship Partner, Bio-Incubator, Eurasanté